Foresite Capital Opportunity Management V, LLC Adicet Bio, Inc. Transaction History
Foresite Capital Opportunity Management V, LLC
- $33.3 Million
- Q3 2022
A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 170,000 shares of ACET stock, worth $214,200. This represents 7.26% of its overall portfolio holdings.
Number of Shares
170,000
Previous 170,000
-0.0%
Holding current value
$214,200
Previous $2.48 Million
2.62%
% of portfolio
7.26%
Previous 6.26%
Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
93Shares Held
66.4MCall Options Held
4.3KPut Options Held
36.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$14.4 Million0.33% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$10.4 Million1.21% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$9.5 Million0.14% of portfolio
-
Goldman Sachs Group Inc New York, NY4.28MShares$5.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.62MShares$4.56 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $50.4M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...